TROSPIUM CHLORIDE (AvKARE, Inc.)
Welcome to the PulseAid listing for the TROSPIUM CHLORIDE drug offered from AvKARE, Inc.. This Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AvKARE, Inc. |
NON-PROPRIETARY NAME: | TROSPIUM CHLORIDE |
SUBSTANCE NAME: | TROSPIUM CHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-10-06 |
END MARKETING DATE: | 0000-00-00 |
TROSPIUM CHLORIDE HUMAN PRESCRIPTION DRUG Details:
Item Description | TROSPIUM CHLORIDE from AvKARE, Inc. |
LABELER NAME: | AvKARE, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 2016-10-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42291-846_0d5b4c31-4333-8963-b3e4-77f03778777b |
PRODUCT NDC: | 42291-846 |
APPLICATION NUMBER: | ANDA091513 |
Other TROSPIUM CHLORIDE Pharmaceutical Manufacturers / Labelers: